09:54 AM EDT, 08/12/2024 (MT Newswires) -- MEI Pharma ( MEIP ) said Monday that it has hired investment banking firm Oppenheimer to be the pharmaceutical company's exclusive financial adviser to review and evaluate strategic alternatives.

The company said it can't guarantee the evaluation of strategic alternatives will lead to any agreements or transactions.

Shares of MEI Pharma ( MEIP ) were up 1.2% in recent trading.

Price: 3.50, Change: +0.04, Percent Change: +1.16